Spain Menopause Market Size & Outlook, 2024-2030

The menopause market in Spain is expected to reach a projected revenue of US$ 452.9 million by 2030. A compound annual growth rate of 6.1% is expected of Spain menopause market from 2025 to 2030.
Revenue, 2024 (US$M)
$317.9
Forecast, 2030 (US$M)
$452.9
CAGR, 2025 - 2030
6.1%
Report Coverage
Spain

Spain menopause market highlights

  • The Spain menopause market generated a revenue of USD 283.7 million in 2022 and is expected to reach USD 452.9 million by 2030.
  • The Spain market is expected to grow at a CAGR of 6% from 2023 to 2030.
  • In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
  • Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.


Menopause market data book summary

Market revenue in 2022USD 283.7 million
Market revenue in 2030USD 452.9 million
Growth rate6% (CAGR from 2022 to 2030)
Largest segmentDietary supplements
Fastest growing segmentDietary Supplements
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOTC pharma products, Dietary Supplements
Key market players worldwideBayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis


Other key industry trends

  • In terms of revenue, Spain accounted for 1.8% of the global menopause market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany menopause market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 452.9 million by 2030.

Dietary supplements was the largest segment with a revenue share of 93.44% in 2024. Horizon Databook has segmented the Spain menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.


Manufacturers are adopting strategies such as the launch of dietary supplements in different flavors to attract more customers. In June 2017, Bioiberica Human Health launched Articolágeno, a food supplement with vitamin C, magnesium, and hydrolyzed collagen. The product contains a patented ingredient, Mobilee, which has a high concentration of hyaluronic acid and is indicated for women at risk of joint pain, especially during menopause.

It was estimated that around 61% of women suffer from joint pain due to decreased estrogen levels during menopause. The high prevalence of health issues associated with menopause and the launch of products focused on meeting the growing health demands are expected to propel the market.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Menopause Market Scope

Menopause market segmentation & scope
Hormonal
Non-Hormonal
Dietary Supplements
Countries
UK
Sweden
Norway
Denmark
Australia
Thailand
Argentina
Saudi Arabia
UAE
Kuwait

Menopause Market Companies

Name Profile # Employees HQ Website

Spain menopause market size, by treatment, 2018-2030 (US$M)

Spain Menopause Market Outlook Share, 2024 & 2030 (US$M)

Spain menopause market size, by treatment, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more